Assignee
SMALL PHARMA LTD
GB·9 granted patents·6 pending applications·83 citations·filing 2017–2022
Top patents by PatentIndex Score
15 records- 0195US11773062B2Deuterated compoundsSMALL PHARMA LTD·Filed 2021·Granted Oct 3, 2023·9 cites·7 claims
- 0295US11660289B2Deuterated or partially deuterated N,N-dimethyltryptamine compoundsSMALL PHARMA LTD·Filed 2022·Granted May 30, 2023·11 cites·15 claims
- 0395US11643390B2Synthesis of N,N-dimethyltryptamine-type compounds, methods, and usesSMALL PHARMA LTD·Filed 2021·Granted May 9, 2023·9 cites·20 claims
- 0495US11578039B2CompoundsSMALL PHARMA LTD·Filed 2022·Granted Feb 14, 2023·9 cites·14 claims
- 0595US11471417B2Deuterated N,N-dimethyltryptamine compoundsSMALL PHARMA LTD·Filed 2021·Granted Oct 18, 2022·16 cites·12 claims
- 0694US11697638B25-methoxy-N,N-dimethyltryptamine crystalline formsSMALL PHARMA LTD·Filed 2021·Granted Jul 11, 2023·10 cites·19 claims
- 0793US11406619B2Injectable formulationsSMALL PHARMA LTD·Filed 2021·Granted Aug 9, 2022·18 cites·20 claims
- 0879US11771681B2Therapeutic compoundsSMALL PHARMA LTD·Filed 2020·Granted Oct 3, 2023·1 cites·9 claims
- 0962US2022306569A1Crystalline forms of hydroxynorketamineSMALL PHARMA LTD·Filed 2022·Application pending·0 cites
- 1058US11377416B2Crystalline forms of hydroxynorketamineSMALL PHARMA LTD·Filed 2018·Granted Jul 5, 2022·0 cites·4 claims
- 1151US2022169606A1Compositions and compounds for bioanalysisSMALL PHARMA LTD·Filed 2020·Application pending·0 cites
- 1249US2022168274A1Parenteral FormulationSMALL PHARMA LTD·Filed 2020·Application pending·0 cites
- 1348US2022062237A1Injectable formulationSMALL PHARMA LTD·Filed 2020·Application pending·0 cites
- 1443US2021315840A1Solid oral dosage forms of ketamine derivativesSMALL PHARMA LTD·Filed 2018·Application pending·0 cites
- 1540US2019380978A1Solid oral dosage forms of 2r,6r-hydroxynorketamine or derivatives thereofSMALL PHARMA LTD·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →